Clear ×
Whitehawk Therapeutics, Inc. WHWK

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 10, 2026 8-K 7 signals fired
Other
Executive Educational Background Disclosure Non Employee Director Compensation Disclosed Classified Board Director Election Kol Endorsement Director Officer Indemnification Provision
Core
Lead Asset Progress Indication Expansion
Aug 6, 2026 10-Q 24 signals fired · top 15
Other
Depreciation Expense Composition Disclosure Net Loss Reported Liquidity Position Snapshot Disclosed Financing Activities Cash Flow Disclosure Institutional Investment Personnel Cost Decrease Disclosure Other Income Expense Disclosure Cash Flow Statement Investing Activities Sga Expense Comparison Disclosed Operating Lease Rent Expense Disclosed Stock Option Intrinsic Value Disclosure Administrative Efficiency Ipo Net Proceeds Disclosure
Core
Regulatory Designation Only Enrollment Failure
Aug 6, 2026 8-K 11 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Quarterly Performance Praise Enrollment Ahead Of Schedule Publication Positive Interim Data Positive
Core
Patient Enrollment Velocity Lead Asset Progress Clinical Trial Result Combination Therapy Mentioned
Biotech v3
Ind Submission Planned
Jun 12, 2026 8-K 2 signals fired
Other
Auditor Appointment Ratification Say On Pay Vote Result Disclosed
May 21, 2026 8-K 11 signals fired
Other
Interim Data Positive Safety Differentiated Fast Track Designation Received Publication Positive Fast Track Granted
Core
Clinical Trial Result Lead Asset Progress Clinical Hold Indication Expansion
Biotech v3
Ind Submission Planned
Biotech Risk
Clinical Hold Active
May 13, 2026 8-K 16 signals fired · top 15
Other
Fcpa Compliance Representation Corporate Organization And Standing Representation Conflicted Defense Counsel Provision Indemnification Consent Requirement Cause For Termination Defined Market Price Definition Exchange Offer Letter Of Transmittal Closing Deliverables Specified Survival Of Representations Warranties Clause Use Of Proceeds Disclosure Amendment Modification Waiver Clause Material Weakness Internal Controls No Broker Fees Representation Institutional Investment Power Of Attorney Disclosure
May 7, 2026 10-Q 40 signals fired · top 15
Other
Restructuring Charge Disclosed Depreciation Expense Composition Disclosure Liquidity Position Snapshot Disclosed Deferred Tax Asset Valuation Disclosure Institutional Investment Net Loss Reported Warrant Valued Black Scholes Other Income Expense Disclosure Financing Activities Cash Flow Disclosure Ipo Net Proceeds Disclosure Rsu Psu Vesting Schedule Disclosed Personnel Cost Decrease Disclosure Segment Aggregation Disclosure Sga Expense Comparison Disclosed Equity Plan Share Reserve Disclosure
May 7, 2026 8-K 9 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Interim Data Positive Kol Endorsement Safety Differentiated
Core
Clinical Trial Result Lead Asset Progress Combination Therapy Mentioned
Biotech v3
Ind Submission Planned